共 50 条
A Fatal Complication of Liver Transplant: Posttransplant Lymphoproliferative Disease
被引:0
|作者:
Hizarcioglu-Gulsen, Hayriye
[1
]
Gumus, Ersin
[1
]
Demir, Hulya
[1
]
Saltik-Temizel, Inci N.
[1
]
Varan, Ali
[2
]
Dincer, Hilmi Anil
[3
]
Dogrul, Ahmet Bulent
[3
]
Ozen, Hasan
[1
]
机构:
[1] Hacettepe Univ, Fac Med, Dept Pediat Gastroenterol Hepatol & Nutr, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Pediat Oncol, Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Gen Surg, Ankara, Turkey
关键词:
Cytomegalovirus;
Epstein-Barr virus;
Lymphoma;
Tacrolimus;
D O I:
10.6002/ect.PediatricSymp2022.O33
中图分类号:
R3 [基础医学];
R4 [临床医学];
学科分类号:
1001 ;
1002 ;
100602 ;
摘要:
Immunosuppressive therapy is a double-edged sword and causes a risk for some complications, such as opportunistic infections and posttransplant lymphoproliferative disease. The most likely risk factors for posttransplant lymphoproliferative disease are Epstein-Barr virus serology mismatch, prolonged and high viral load for Epstein-Barr virus, higher doses of immunosuppressive therapy, and cytomegalovirus infection. Transplant recipients who are seropositive for Epstein-Barr virus show a lower risk for posttransplant lymphoproliferative disease than seronegative recipients. Here, we present a 3.5-year-old boy who was seropositive for Epstein-Barr virus and developed posttransplant lymphoproliferative disease 18 months after liver transplant with a previous history of cytomegalovirusrelated pneumatosis intestinalis.
引用
收藏
页码:102 / 104
页数:3
相关论文